Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Managed Health Care - NEC
- Sub-Industry: Managed Health Care
- Symbol: NYSE:CI
- CUSIP: 12550910
- Web: www.cigna.com
Capitalization:- Market Cap: $45.28481 billion
- Outstanding Shares: 251,778,000
Average Prices:- 50 Day Moving Avg: $173.37
- 200 Day Moving Avg: $160.06
- 52 Week Range: $115.03 - $181.00
P/E:- Trailing P/E Ratio: 20.54
- Foreward P/E Ratio: 15.66
- P/E Growth: 1.25
Sales & Book Value:- Annual Revenue: $40.53 billion
- Price / Sales: 1.11
- Book Value: $57.56 per share
- Price / Book: 3.09
Dividend:- Annual Dividend: $0.04
- Dividend Yield: 0.0%
Profitability:- EBIDTA: $4.21 billion
- Net Margins: 5.55%
- Return on Equity: 17.40%
- Return on Assets: 4.04%
Debt:- Debt-to-Equity Ratio: 0.32%
- Current Ratio: 0.40%
- Quick Ratio: 0.40%
Misc:- Average Volume: 1.44 million shs.
- Beta: 0.46
- Short Ratio: 2.3
Frequently Asked Questions for Cigna Corporation (NYSE:CI)
What is Cigna Corporation's stock symbol?
Cigna Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does Cigna Corporation pay dividends? What is the dividend yield for Cigna Corporation?
Cigna Corporation declared a quarterly dividend on Wednesday, February 22nd. Stockholders of record on Friday, March 10th will be paid a dividend of $0.04 per share on Monday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.09%. The ex-dividend date is Wednesday, March 8th. View Cigna Corporation's Dividend History.
How will Cigna Corporation's stock buyback program work?
Cigna Corporation announced that its board has authorized a stock repurchase program on Sunday, June 4th 2017, which authorizes the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 9.8% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board believes its shares are undervalued.
How were Cigna Corporation's earnings last quarter?
Cigna Corporation (NYSE:CI) released its earnings results on Friday, August, 4th. The company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.48 by $0.43. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation's quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.98 EPS. View Cigna Corporation's Earnings History.
When will Cigna Corporation make its next earnings announcement?
What guidance has Cigna Corporation issued on next quarter's earnings?
Cigna Corporation issued an update on its FY17 earnings guidance on Friday, August, 4th. The company provided earnings per share guidance of $9.75-10.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.78.
Where is Cigna Corporation's stock going? Where will Cigna Corporation's stock price be in 2017?
17 brokerages have issued 1-year price objectives for Cigna Corporation's shares. Their forecasts range from $134.00 to $198.00. On average, they expect Cigna Corporation's stock price to reach $180.00 in the next year. View Analyst Ratings for Cigna Corporation.
What are analysts saying about Cigna Corporation stock?
Here are some recent quotes from research analysts about Cigna Corporation stock:
- 1. According to Zacks Investment Research, "Cigna’s shares have outperformed the industry, year to date. The company’s second-quarter 2017 earnings beat the Zacks Consensus Estimate and increased year over year, reflecting strong contribution from each of the company’s business segments. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing Government business and increasing membership. A strong capital position and resumption of share buyback are the other positives. Cigna is engaged in a legal tussle with Anthem and thus the termination fee and other charges that it were to receive from the latter remain uncertain. Increase in benefits and expenses continue to bother us." (8/8/2017)
- 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)
Who are some of Cigna Corporation's key competitors?
Who are Cigna Corporation's key executives?
Cigna Corporation's management team includes the folowing people:
- Isaiah Harris Jr., Independent Chairman of the Board
- David M. Cordani, President, Chief Executive Officer, Director
- Eric P. Palmer, Chief Financial Officer, Executive Vice President
- CHRISTOPHER HOCEVAR, President, Strategy, Segments and Solutions
- Matthew G. Manders, President - Government & Individual Programs and Group Insurance
- Jason Dominic Sadler, President - International Markets.
- MICHAEL TRIPLETT, is President, U.S. Markets
- Mark L. Boxer, Global Chief Information Officer, Executive Vice President
- Lisa R. Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
- Nicole S. Jones, Executive Vice President, General Counsel
Who owns Cigna Corporation stock?
Cigna Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (6.69%), BlackRock Inc. (6.59%), Dodge & Cox (5.43%), State Street Corp (4.36%), FMR LLC (2.70%) and JPMorgan Chase & Co. (1.60%). Company insiders that own Cigna Corporation stock include David Cordani, Herbert A Fritch, Isaiah Harris Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones and Thomas A Mccarthy. View Institutional Ownership Trends for Cigna Corporation.
Who sold Cigna Corporation stock? Who is selling Cigna Corporation stock?
Cigna Corporation's stock was sold by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Balyasny Asset Management LLC, Maverick Capital Ltd., Franklin Resources Inc., Boston Partners, Wells Fargo & Company MN, Dodge & Cox and Pzena Investment Management LLC. Company insiders that have sold Cigna Corporation stock in the last year include David Cordani, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones and Thomas A Mccarthy. View Insider Buying and Selling for Cigna Corporation.
Who bought Cigna Corporation stock? Who is buying Cigna Corporation stock?
Cigna Corporation's stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., FMR LLC, Arrowstreet Capital Limited Partnership, Vanguard Group Inc., American Century Companies Inc., Numeric Investors LLC, Old Mutual Global Investors UK Ltd. and Prudential Financial Inc.. View Insider Buying and Selling for Cigna Corporation.
How do I buy Cigna Corporation stock?
Shares of Cigna Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cigna Corporation's stock price today?
One share of Cigna Corporation stock can currently be purchased for approximately $178.03.
MarketBeat Community Rating for Cigna Corporation (NYSE CI)MarketBeat's community ratings are surveys of what our community members think about Cigna Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Cigna Corporation (NYSE:CI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 15 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.88) |
| Consensus Price Target: | $180.00 (1.11% upside) |
Analysts' Ratings History for Cigna Corporation (NYSE:CI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/17/2017 | Morgan Stanley | Boost Price Target | Overweight | $188.00 -> $195.00 | Low |  |
| 8/9/2017 | Royal Bank Of Canada | Reiterated Rating | Buy | $185.00 | High | |
| 8/7/2017 | Citigroup Inc. | Boost Price Target | Buy | $185.00 -> $198.00 | Low | |
| 8/7/2017 | Deutsche Bank AG | Boost Price Target | Buy | $180.00 -> $190.00 | Low | |
| 8/4/2017 | Credit Suisse Group | Reiterated Rating | Buy | $196.00 | High | |
| 8/4/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $199.00 -> $190.00 | Low | |
| 7/28/2017 | Piper Jaffray Companies | Reiterated Rating | Buy | $175.00 | Medium | |
| 6/23/2017 | Bank of America Corporation | Boost Price Target | Buy | $193.00 -> $198.00 | Medium | |
| 6/19/2017 | Wells Fargo & Company | Reiterated Rating | Market Perform | $163.00 -> $174.00 | Low | |
| 6/15/2017 | CIBC | Boost Price Target | Outperform | $174.00 -> $185.00 | Medium | |
| 6/15/2017 | Oppenheimer Holdings, Inc. | Boost Price Target | Outperform | $174.00 -> $185.00 | Low | |
| 6/1/2017 | Cowen and Company | Reiterated Rating | Outperform | $160.00 -> $185.00 | Low | |
| 5/15/2017 | Stifel Nicolaus | Boost Price Target | Buy | $170.00 -> $175.00 | N/A | |
| 9/26/2016 | Leerink Swann | Reiterated Rating | Buy | $155.00 | N/A | |
| 9/22/2016 | Evercore ISI | Initiated Coverage | Hold | $134.00 | N/A | |
| 9/8/2016 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Buy | $160.00 | N/A | |
| 8/31/2016 | William Blair | Reiterated Rating | Buy | | N/A | |
| 6/28/2016 | Wolfe Research | Initiated Coverage | Outperform | $172.00 | N/A | |
| 6/20/2016 | FBR & Co | Reiterated Rating | Hold | | N/A | |
| 6/1/2016 | Barclays PLC | Boost Price Target | Equal Weight | $156.00 -> $168.00 | N/A | |
| 2/5/2016 | BMO Capital Markets | Lower Price Target | Outperform | $167.00 -> $165.00 | N/A | |
| 1/24/2016 | Sterne Agee CRT | Reiterated Rating | Buy | | N/A | |
| 11/9/2015 | Wedbush | Reiterated Rating | Hold | $186.00 -> $175.00 | N/A | |
| 9/16/2015 | J P Morgan Chase & Co | Initiated Coverage | Overweight | $175.00 | N/A | |
(Data available from 8/18/2015 forward)
Earnings History for Cigna Corporation (NYSE:CI)Earnings History by Quarter for Cigna Corporation (NYSE CI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/2/2017 | | | | | | | N/A | |
| 8/4/2017 | Q2 2017 | $2.48 | $2.91 | $10.26 billion | $10.32 billion | View | N/A | |
| 5/5/2017 | Q1 2017 | $2.44 | $2.77 | $10.11 billion | $10.39 billion | View | N/A | |
| 2/2/2017 | Q416 | $1.74 | $1.87 | $9.88 billion | $9.94 billion | View | Listen | |
| 11/3/2016 | Q316 | $1.91 | $1.94 | $4.37 billion | $9.90 billion | View | N/A | |
| 7/29/2016 | Q216 | $2.39 | $1.98 | $9.98 billion | $9.89 billion | View | Listen | |
| 5/6/2016 | Q116 | $2.16 | $2.32 | $9.98 billion | $9.90 billion | View | N/A | |
| 2/4/2016 | Q415 | $1.80 | $1.87 | $9.52 billion | $9.53 billion | View | N/A | |
| 11/6/2015 | Q315 | $2.18 | $2.28 | $9.51 billion | $9.39 billion | View | N/A | |
| 7/30/2015 | Q215 | $2.38 | $2.55 | $9.53 billion | $9.50 billion | View | N/A | |
| 4/30/2015 | Q115 | $1.85 | $1.96 | $9.28 billion | $9.50 billion | View | N/A | |
| 2/5/2015 | Q414 | $1.65 | $1.69 | $8.89 billion | $8.93 billion | View | N/A | |
| 10/30/2014 | Q314 | $1.81 | $1.95 | $8.64 billion | $8.80 billion | View | N/A | |
| 7/31/2014 | Q214 | $1.85 | $1.96 | $7.61 billion | $8.73 billion | View | N/A | |
| 5/1/2014 | Q114 | $1.54 | $1.83 | $7.72 billion | $8.50 billion | View | Listen | |
| 2/7/2014 | Q413 | $1.63 | $1.39 | $7.30 billion | $8.15 billion | View | Listen | |
| 10/31/2013 | Q313 | $1.62 | $1.89 | $7.24 billion | $8.07 billion | View | Listen | |
| 8/1/2013 | Q2 2013 | $1.60 | $1.78 | $7.38 billion | $7.98 billion | View | N/A | |
| 5/2/2013 | Q1 2013 | $1.42 | $1.72 | $7.25 billion | $8.18 billion | View | Listen | |
| 2/7/2013 | Q4 2012 | $1.48 | $1.41 | $6.72 billion | $7.62 billion | View | Listen | |
| 11/1/2012 | Q312 | $1.36 | $1.71 | $6.63 billion | $7.36 billion | View | N/A | |
| 8/2/2012 | | $1.41 | $1.52 | | | View | N/A | |
| 5/3/2012 | | $1.30 | $1.28 | | | View | N/A | |
| 2/2/2012 | | $1.18 | $1.11 | | | View | N/A | |
| 10/28/2011 | | $1.22 | $1.20 | | | View | N/A | |
| 8/4/2011 | | $1.29 | $1.53 | | | View | N/A | |
| 5/5/2011 | | $1.09 | $1.37 | | | View | N/A | |
| 2/3/2011 | | $1.02 | $1.15 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cigna Corporation (NYSE:CI)2017 EPS Consensus Estimate: $9.61
2018 EPS Consensus Estimate: $10.87
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 4 | $2.36 | $2.56 | $2.45 |
| Q2 2017 | 4 | $2.44 | $2.87 | $2.58 |
| Q3 2017 | 4 | $2.30 | $2.68 | $2.42 |
| Q4 2017 | 4 | $2.06 | $2.26 | $2.17 |
| Q1 2018 | 1 | $2.81 | $2.81 | $2.81 |
| Q2 2018 | 1 | $2.87 | $2.87 | $2.87 |
| Q3 2018 | 1 | $2.71 | $2.71 | $2.71 |
| Q4 2018 | 1 | $2.48 | $2.48 | $2.48 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Cigna Corporation (NYSE:CI)| Most Recent Dividend: | 4/10/2017 |
| Annual Dividend: | $0.04 |
| Dividend Yield: | 0.02% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 0.46% (Trailing 12 Months of Earnings)
0.40% (Based on This Year's Estimates)
0.35% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Cigna Corporation (NYSE CI)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/22/2017 | quarterly | $0.04 | 0.03% | 3/8/2017 | 3/10/2017 | 4/10/2017 |
| 2/25/2016 | annual | $0.04 | 0.03% | 3/9/2016 | 3/11/2016 | 4/11/2016 |
| 2/26/2015 | annual | $0.04 | 0.03% | 3/10/2015 | 3/12/2015 | 4/10/2015 |
| 2/26/2014 | quarterly | $0.04 | 0.05% | 3/10/2014 | 3/12/2014 | 4/9/2014 |
| 3/1/2013 | annual | $0.04 | 0.07% | 3/8/2013 | 3/12/2013 | 4/10/2013 |
| 2/28/2013 | quarterly | $0.04 | | | 3/12/2013 | 4/10/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Cigna Corporation (NYSE:CI)Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 87.61%
Insider Trades by Quarter for Cigna Corporation (NYSE:CI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/16/2017 | Lisa R Bacus | EVP | Sell | 2,236 | $179.95 | $402,368.20 | |
| 8/9/2017 | Mary T Hoeltzel | VP | Sell | 525 | $177.59 | $93,234.75 | |
| 8/8/2017 | Michael W Triplett | Insider | Sell | 3,700 | $174.96 | $647,352.00 | |
| 8/7/2017 | Jason D Sadler | Insider | Sell | 37,756 | $176.16 | $6,651,096.96 | |
| 7/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $174.14 | $104,484.00 | |
| 7/21/2017 | Matthew G Manders | Insider | Sell | 24,357 | $175.01 | $4,262,718.57 | |
| 6/19/2017 | David Cordani | CEO | Sell | 153,168 | $170.20 | $26,069,193.60 | |
| 6/14/2017 | Michael W Triplett | Insider | Sell | 1,439 | $166.89 | $240,154.71 | |
| 6/6/2017 | Mary T Hoeltzel | VP | Sell | 500 | $166.70 | $83,350.00 | |
| 6/5/2017 | Jason D Sadler | Insider | Sell | 1,727 | $164.59 | $284,246.93 | |
| 6/2/2017 | Matthew G Manders | Insider | Sell | 6,000 | $165.00 | $990,000.00 | |
| 5/24/2017 | Lisa R Bacus | EVP | Sell | 11,455 | $161.57 | $1,850,784.35 | |
| 5/17/2017 | Nicole S Jones | EVP | Sell | 20,312 | $160.04 | $3,250,732.48 | |
| 4/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $156.92 | $94,152.00 | |
| 4/10/2017 | Jason D Sadler | Insider | Sell | 4,213 | $152.01 | $640,418.13 | |
| 2/27/2017 | David Cordani | CEO | Sell | 43,637 | $147.78 | $6,448,675.86 | |
| 2/27/2017 | Matthew G Manders | Insider | Sell | 8,309 | $146.54 | $1,217,600.86 | |
| 2/27/2017 | Thomas A Mccarthy | CFO | Sell | 4,464 | $146.54 | $654,154.56 | |
| 12/20/2016 | Jason D Sadler | Insider | Sell | 2,000 | $138.10 | $276,200.00 | |
| 11/7/2016 | John M Murabito | EVP | Sell | 58,822 | $125.09 | $7,358,043.98 | |
| 10/31/2016 | Jason D Sadler | Insider | Sell | 4,000 | $121.80 | $487,200.00 | |
| 8/17/2016 | Mary T Hoeltzel | VP | Sell | 500 | $132.28 | $66,140.00 | |
| 12/8/2015 | Isaiah Harris Jr | Chairman | Sell | 333 | $137.00 | $45,621.00 | |
| 11/16/2015 | Herbert A. Fritch | insider | Sell | 40,157 | $133.18 | $5,348,109.26 | |
| 10/15/2015 | Herbert A. Fritch | insider | Sell | 39,202 | $136.66 | $5,357,345.32 | |
| 9/15/2015 | Herbert A. Fritch | insider | Sell | 39,174 | $139.66 | $5,471,040.84 | |
| 8/17/2015 | Herbert A Fritch | Insider | Sell | 38,489 | $144.36 | $5,556,272.04 | |
| 7/15/2015 | Herbert A Fritch | Insider | Sell | 37,918 | $155.96 | $5,913,691.28 | |
| 6/15/2015 | Herbert A Fritch | Insider | Sell | 38,045 | $145.15 | $5,522,231.75 | |
| 6/8/2015 | Isaiah Harris Jr | Chairman | Sell | 319 | $139.48 | $44,494.12 | |
| 4/15/2015 | Herbert A Fritch | Insider | Sell | 38,080 | $132.99 | $5,064,259.20 | |
| 3/16/2015 | Herbert A Fritch | Insider | Sell | 38,377 | $124.40 | $4,774,098.80 | |
| 3/9/2015 | Isaiah Harris Jr | Chairman | Sell | 369 | $120.64 | $44,516.16 | |
| 3/2/2015 | Nicole S Jones | EVP | Sell | 8,659 | $121.88 | $1,055,358.92 | |
| 2/10/2015 | Mary T Hoeltzel | CAO | Sell | 6,805 | $113.29 | $770,938.45 | |
| 1/15/2015 | Herbert A Fritch | Insider | Sell | 35,864 | $107.04 | $3,838,882.56 | |
| 12/15/2014 | Herbert A Fritch | Insider | Sell | 35,929 | $101.67 | $3,652,901.43 | |
| 12/8/2014 | Isaiah Harris Jr | Chairman | Sell | 437 | $104.60 | $45,710.20 | |
| 12/1/2014 | John M Murabito | EVP | Sell | 12,000 | $102.76 | $1,233,120.00 | |
| 9/10/2014 | Jane E Md Henney | Director | Sell | 475 | $95.98 | $45,590.50 | |
| 8/18/2014 | Jason D Sadler | Insider | Sell | 11,000 | $93.02 | $1,023,220.00 | |
| 8/1/2014 | Isaiah Harris Jr | Chairman | Sell | 1,066 | $90.22 | $96,174.52 | |
| 6/13/2014 | Thomas A Mccarthy | CFO | Sell | 7,206 | $90.26 | $650,413.56 | |
| 6/12/2014 | Nicole S Jones | EVP | Sell | 1,882 | $91.02 | $171,299.64 | |
| 6/11/2014 | John M Murabito | EVP | Sell | 17,519 | $91.25 | $1,598,608.75 | |
| 6/10/2014 | David Cordani | CEO | Sell | 133,523 | $89.73 | $11,981,018.79 | |
| 6/2/2014 | David D Guilmette | Insider | Sell | 6,591 | $90.19 | $594,442.29 | |
| 5/13/2014 | Jason Sadler | Insider | Sell | 6,145 | $88.50 | $543,832.50 | |
| 5/12/2014 | Matthew Manders | Insider | Sell | 9,905 | $87.79 | $869,559.95 | |
| 5/8/2014 | Jason Sadler | Insider | Sell | 7,810 | $85.59 | $668,457.90 | |
| 5/7/2014 | Mary Hoeltzel | CAO | Sell | 3,000 | $85.00 | $255,000.00 | |
| 3/14/2014 | John Murabito | EVP | Sell | 29,843 | $76.70 | $2,288,958.10 | |
| 3/14/2014 | Mary Hoeltzel | CAO | Sell | 5,333 | $77.72 | $414,480.76 | |
| 9/12/2013 | Nicole Jones | EVP | Sell | 1,530 | $82.35 | $125,995.50 | |
| 9/6/2013 | John M Murabito | EVP | Sell | 24,333 | $81.07 | $1,972,676.31 | |
| 8/16/2013 | Jason Sadler | Insider | Sell | 13,261 | $77.81 | $1,031,838.41 | |
| 8/14/2013 | Mary Hoeltzel | CAO | Sell | 8,664 | $78.26 | $678,044.64 | |
| 8/7/2013 | John Murabito | EVP | Sell | 78,589 | $77.89 | $6,121,297.21 | |
| 6/13/2013 | David Cordani | CEO | Sell | 58,705 | $68.63 | $4,028,924.15 | |
| 6/12/2013 | Matthew G Manders | Insider | Sell | 36,868 | $68.75 | $2,534,675.00 | |
| 6/12/2013 | Nicole S Jones | EVP | Sell | 15,306 | $70.08 | $1,072,644.48 | |
| 6/5/2013 | Isaiah Harris Jr | Chairman | Sell | 5,312 | $67.40 | $358,028.80 | |
| 3/11/2013 | Mary T Hoeltzel | CAO | Sell | 5,712 | $60.50 | $345,576.00 | |
| 3/6/2013 | Eric C Wiseman | Director | Buy | 4,200 | $59.30 | $249,060.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Cigna Corporation (NYSE:CI)
Latest Headlines for Cigna Corporation (NYSE:CI)
| Source: |
|
| Date | Headline |
|---|
 | Insider Selling: Cigna Corporation (CI) EVP Sells 2,236 Shares of Stock
www.americanbankingnews.com - August 17 at 7:22 PM |
| Cigna Corporation (CI) PT Raised to $195.00
www.americanbankingnews.com - August 17 at 5:32 PM |
| Insider Selling: Cigna Corporation (CI) VP Sells 525 Shares of Stock
www.americanbankingnews.com - August 11 at 8:56 PM |
| Cigna Corporation (CI) Insider Sells $647,352.00 in Stock
www.americanbankingnews.com - August 10 at 7:48 PM |
 | See what the IHS Markit Score report has to say about Cigna Corp.
finance.yahoo.com - August 10 at 6:28 PM |
| IHS Markit Score Update: Drop in demand for ETFs holding Cigna Corp is a negative sign for its shares
finance.yahoo.com - August 10 at 6:28 PM |
| Jason D. Sadler Sells 37,756 Shares of Cigna Corporation (NYSE:CI) Stock
www.americanbankingnews.com - August 9 at 7:34 PM |
 | Cigna Roots for the Home Team with Sponsorship of the Hartford ... - Business Wire (press release)
www.businesswire.com - August 9 at 5:21 PM |
| Cigna Roots for the Home Team with Sponsorship of the Hartford Yard Goats
finance.yahoo.com - August 9 at 5:21 PM |
| Cigna Corporation (CI) Forecasted to Post Q3 2017 Earnings of $2.32 Per Share
www.americanbankingnews.com - August 9 at 8:10 AM |
| Cigna Corporation (NYSE:CI) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - August 8 at 8:50 AM |
| Cigna Corporation to Post FY2017 Earnings of $10.05 Per Share, Leerink Swann Forecasts (CI)
www.americanbankingnews.com - August 8 at 7:04 AM |
| Today's Research Reports on Stocks to Watch: Arista Networks and Cigna Corporation
finance.yahoo.com - August 7 at 5:36 PM |
| Cigna Corporation (NYSE:CI) PT Raised to $190.00
www.americanbankingnews.com - August 7 at 4:56 PM |
| Cigna Corporation (NYSE:CI) Given New $188.00 Price Target at Morgan Stanley
www.americanbankingnews.com - August 7 at 3:38 PM |
| Citigroup Inc. Boosts Cigna Corporation (CI) Price Target to $198.00
www.americanbankingnews.com - August 7 at 3:38 PM |
| Cigna CEO: Obamacare marketplace remains 'challenging' for 2017, 2018
finance.yahoo.com - August 6 at 4:29 PM |
| Credit Suisse Group Reiterates Buy Rating for Cigna Corporation (CI)
www.americanbankingnews.com - August 5 at 9:20 PM |
 | UPDATE 3-Cigna says costs drop but keeps eye on Obamacare spending
www.cnbc.com - August 5 at 3:33 AM |
| Edited Transcript of CI earnings conference call or presentation 4-Aug-17 12:00pm GMT
finance.yahoo.com - August 5 at 3:33 AM |
 | Mid-Afternoon Market Update: Natural Grocers Drops On Disappointing Earnings; Yelp Shares Spike Higher - Benzinga
www.benzinga.com - August 4 at 10:30 PM |
| Mid-Morning Market Update: Markets Mostly Flat; CIGNA Profit Tops Estimates - Benzinga
www.benzinga.com - August 4 at 10:30 PM |
| Cigna Corporation (NYSE:CI) Announces Earnings Results
www.americanbankingnews.com - August 4 at 8:38 PM |
 | Cigna (CI) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 4 at 5:28 PM |
| Cigna Reports Strong Second Quarter 2017 Results, Raises Outlook
www.businesswire.com - August 4 at 5:28 PM |
 | Cigna Lifts FY17 Forecast As Q2 Earnings Top View
www.rttnews.com - August 4 at 5:28 PM |
 | BRIEF-Cigna Corp Q2 adjusted operating earnings per share $2.91
www.reuters.com - August 4 at 5:28 PM |
| Health insurer Cigna posts 59 pct rise in quarterly profit
finance.yahoo.com - August 4 at 5:28 PM |
| Big Health Insurers Beat on Wall Street, Ignoring D.C. Chaos
finance.yahoo.com - August 4 at 5:28 PM |
| Health insurer Cigna beats profit estimates, raises FY profit view
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna Corp.'s (CI) Q2 Earnings and Revenues Beat, Guides Up
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna profit and revenue rise, beat expectations
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna Profits Jump 46% Despite Obamacare Loss
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna CEO: Obamacare marketplace remains 'challenging' for 2017, 2018
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna tops Street 2Q forecasts
finance.yahoo.com - August 4 at 5:28 PM |
| Cigna Corporation (NYSE:CI) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - August 4 at 1:48 PM |
| Mid-Morning Market Update: Markets Mostly Flat; CIGNA Profit Tops Estimates
feeds.benzinga.com - August 4 at 11:17 AM |
| Cigna Corporation (NYSE:CI) Issues FY17 Earnings Guidance
www.americanbankingnews.com - August 4 at 9:28 AM |
 | Autosoft Wins Cigna Well-Being Award
www.bizjournals.com - August 3 at 11:48 PM |
 | 3 Reasons Why Cigna Corporation (CI) Is Poised To Beat Earnings - Nasdaq
www.nasdaq.com - August 3 at 6:46 PM |
 | Earnings Preview: What To Expect From Cigna On Friday - Forbes
www.forbes.com - August 3 at 6:46 PM |
| 3 Reasons Why Cigna Corporation (CI) Is Poised To Beat Earnings
finance.yahoo.com - August 3 at 6:46 PM |
| Apple, 2 Top iPhone Chip Stocks, Jobs Headline Friday's Action Plan
finance.yahoo.com - August 3 at 6:46 PM |
| Should You Buy Cigna Corporation (CI) Ahead of Earnings? - Nasdaq
www.nasdaq.com - August 2 at 11:00 PM |
| Should You Buy Cigna Corporation (CI) Ahead of Earnings?
finance.yahoo.com - August 2 at 5:58 PM |
| Is a Beat in Store for Cigna Corp (CI) This Earnings Season?
finance.yahoo.com - August 2 at 5:58 PM |
 | NC's Blue Cross cutting rate request on individual policies
marketbeat.com - August 2 at 11:39 AM |
| N.C. lab that filed lawsuit against Cigna no longer in operation
www.bizjournals.com - August 1 at 5:54 PM |
| Cigna Foundation Gives $150000 Grant and Cigna Donates Vehicle for Mobile Dental Care Provided by Appalachian ... - Business Wire (press release)
www.businesswire.com - July 31 at 10:09 PM |
| Cigna Corporation (CI) and Humana (HUM) Head to Head Review
www.americanbankingnews.com - July 31 at 8:26 PM |
Cigna Corporation (CI) Chart for Friday, August, 18, 2017
